MCID: MMP001
MIFTS: 57

Mumps malady

Categories: Rare diseases, Infectious diseases, Oral diseases

Aliases & Classifications for Mumps

About this section

Aliases & Descriptions for Mumps:

Name: Mumps 10 45 47 12 36 35 2 65

Classifications:



External Ids:

Disease Ontology10 DOID:10264
ICD1027 B26, B26.9, B26.8
ICD9CM29 072
MeSH36 D009107
NCIt42 C29888
UMLS65 C0026780

Summaries for Mumps

About this section
MedlinePlus:35 Mumps is an illness caused by the mumps virus. it starts with fever headache muscle aches tiredness loss of appetite after that, the salivary glands under the ears or jaw become swollen and tender. the swelling can be on one or both sides of the face. symptoms last 7 to 10 days. serious complications are rare. you can catch mumps by being with another person who has it. there is no treatment for mumps, but the measles-mumps-rubella (mmr) vaccine can prevent it. before the routine vaccination program in the united states, mumps was a common illness in infants, children and young adults. now it is a rare disease in the u.s. centers for disease control and prevention

MalaCards based summary: Mumps is related to encephalitis and congenital mumps, and has symptoms including fever, headache and muscle aches. An important gene associated with Mumps is STAT2 (Signal Transducer And Activator Of Transcription 2), and among its related pathways are Osteoclast differentiation and Immune response IFN gamma signaling pathway. Affiliated tissues include salivary gl, salivary gland and brain, and related mouse phenotypes are liver/biliary system and endocrine/exocrine gland.

Disease Ontology:10 A viral infectious disease that results in inflammation located in salivary gland, has material basis in Mumps virus, which is transmitted by droplet spread of saliva or mucus from the mouth, nose, or throat of an infected person, or transmitted by contaminated fomites. The infection has symptom fever, has symptom headache, has symptom muscle aches, has symptom tiredness, has symptom loss of appetite, has symptom swollen and tender salivary glands under the ears or jaw on one or both sides of the face.

CDC:2 Mumps is a contagious disease caused by a virus. It typically starts with a few days of fever, headache, muscle aches, tiredness, and loss of appetite, followed by swollen salivary glands. You can protect yourself and your family against mumps with vaccination.

Wikipedia:68 Mumps, also known as epidemic parotitis, is a viral disease caused by the mumps virus. Initial signs and... more...

Related Diseases for Mumps

About this section

Diseases in the Mumps family:

Congenital Mumps

Diseases related to Mumps via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 218)
idRelated DiseaseScoreTop Affiliating Genes
1encephalitis31.2STAT1, STAT2
2congenital mumps12.1
3rubella11.1
4measles11.1
5photokeratitis10.6IFNG, STAT1
6non-distal monosomy 10q10.6HLA-DRB1, IFNG
7red cell phospholipid defect with hemolysis10.6HLA-DRB1, IFNG
8scleritis10.6CD40LG, STAT1
9beriberi10.6CD40LG, IFNG
10bacillary angiomatosis10.6CD40LG, IFNG
11demyelinating polyneuropathy10.6IFNG, STAT1
12pityriasis rosea10.6CD40LG, HLA-DRB1
13louping ill10.5CD40LG, IFNG
14pulmonary nodular lymphoid hyperplasia10.5HLA-DRB1, IFNG
15myofascial pain syndrome10.5HLA-DRB1, IFNG, STAT1
16cycloplegia10.4IFNG, IL2RA
17lujo hemorrhagic fever10.4HLA-DRB1, IL6
18lower gum cancer10.4IFNG, IRF2
19graft-versus-host disease, protection against10.4IFNG, IL2RA
20chronic hiccups10.4IFNG, IL2RA
21orchitis10.4
22endotheliitis10.4
23plasma protein metabolism disease10.4CD40LG, IL6
24meningitis10.4
25b cell deficiency10.4CD40LG, IFNG
26cytoplasmic body myopathy10.3HLA-DRB1, IFNG
27wrinkles10.3CD40LG, IL6
28acute hemorrhagic leukoencephalitis10.3
29acute disseminated encephalomyelitis10.3
30intestinal impaction10.3CD40LG, IL6
31limited scleroderma10.3CD40LG, HLA-DRB1, IFNG
32aseptic meningitis10.3
33early-onset, autosomal dominant alzheimer disease10.3IFNG, IL6
34angioid streaks10.3HLA-DRB1, IL2RA
35refractory plasma cell neoplasm10.3CD40LG, IL6
36parotitis10.3
37cd3delta deficiency10.2IL12RB2, IL2RA
38motion sickness10.2IFNG, IL6, STAT1
39penile disease10.2IFNG, IL2RA
40leukoplakia of penis10.2IFNG, IL12RB2, IL18R1
41vulvar disease10.2IFNG, IL2RA, STAT1
42collagenous colitis10.2HLA-DRB1, IFNG, IL6
43hypercementosis10.2HLA-DRB1, IFNG, IL2RA
44skin conditions10.2IL12RB2, IL6
45inflammatory leiomyosarcoma10.2CD40LG, HLA-DRB1, IL6
46keratomalacia10.2CD40LG, HLA-DRB1, IL6
47lateral sclerosis10.2CD40LG, HLA-DRB1, IL6
48pupil disease10.2HLA-DRB1, IFNG, IL6
49congenital dyserythropoietic anemia10.2CD40LG, IFNG, IL6
50meige syndrome10.1CD40LG, IFNG, IL6

Graphical network of the top 20 diseases related to Mumps:



Diseases related to mumps

Symptoms for Mumps

About this section

Symptoms:

 10
  • fever
  • headache
  • muscle aches
  • tiredness
  • loss of appetite
  • swollen

UMLS symptoms related to Mumps:


pruritus

Drugs & Therapeutics for Mumps

About this section

Drugs for Mumps (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 33)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1Pharmaceutical SolutionsPhase 4, Phase 3, Phase 27004
2Heptavalent Pneumococcal Conjugate VaccinePhase 4, Phase 3, Phase 2440
3AntibodiesPhase 4, Phase 2, Phase 14477
4VaccinesPhase 4, Phase 3, Phase 2, Phase 1, Phase 06085
5Immunologic FactorsPhase 4, Phase 3, Phase 2, Phase 118483
6ImmunoglobulinsPhase 4, Phase 2, Phase 14477
7Liver ExtractsPhase 43572
8
Aluminum hydroxideapprovedPhase 3, Phase 2178
Synonyms:
Al(OH)3
Aluminiumhydroxid
 
Aluminum Hydroxide
Aluminum hydroxide
Dermadrox
9PENTAPhase 3, Phase 2109
10
LactitolPhase 3, Phase 2320585-86-43871
Synonyms:
4-O-b-D-Galactopyranosyl-D-glucitol, 9CI
E966
Emportal
 
Floralac
Importal
Oponaf
Portolac
11
Daclizumabapproved, investigationalPhase 296152923-56-3
Synonyms:
Anti-IL-2
Humanized antiCD25
 
Ig gamma-1 chain C region
Simulect
chimeric mouse-human antiCD25
12
AltretamineapprovedPhase 257645-05-62123
Synonyms:
2,4, 6-Tris(dimethylamino)-1,3,5-triazine
2,4,6-Tris(dimethylami
2,4,6-Tris(dimethylamino)-1,3,5-triazine
2,4,6-Tris(dimethylamino)-S-triazine
2,4,6-Tris(dimethylamino)-s-triazine
2-N,2-N,4-N,4-N,6-N,6-N-hexamethyl-1,3,5-triazine-2,4,6-triamine
549835_ALDRICH
645-05-6
A 8723
A0567/0026158
A8723_SIGMA
AB00052308
AC-12006
AC1L1CYX
AI3-50852
AKOS001729401
Altretamin
Altretamina
Altretamina [INN-Spanish]
Altretamine (USP/INN)
Altretamine Bellon Brand
Altretamine Chiesi Brand
Altretamine Wassermann Brand
Altretamine [USAN:INN:BAN]
Altretaminum
Altretaminum [INN-Latin]
Altrétamine
BPBio1_001004
BRD-K67043667-001-04-1
BRN 0195058
BSPBio_000912
Bellon Brand of Altretamine
C9H18N6
CAS-654-05-6
CCRIS 5492
CHEBI:24564
CHEMBL1455
CID2123
CPD000058181
ChemDiv2_005185
Chiesi Brand of Altretamine
D006585
D02841
DB00488
DivK1c_000772
EINECS 211-428-4
ENT 50852
EU-0100083
FT-0083576
HEXAMETHYLMELAMINE
HMM
HMS1383L15
HMS1570N14
HMS1922C05
HMS2090G17
HMS2092H16
HMS502G14
HSDB 7559
HTM
HXM
Hemel
Hexalen
Hexalen (TN)
Hexalen, Altretamine
 
Hexamethylmelamine
Hexastat
Hexinawas
I06-0604
IDI1_000772
IDI1_003900
InChI=1/C9H18N6/c1-13(2)7-10-8(14(3)4)12-9(11-7)15(5)6/h1-6H
KB-913
KBio1_000772
KBio2_001788
KBio2_004356
KBio2_006924
KBio3_002042
KBioGR_001388
KBioSS_001788
LS-1549
Lopac-A-8723
Lopac0_000083
MGI Pharma Brand of Altretamine
MLS000069621
MLS001076123
MolPort-002-111-210
N,N,N',N',N'',N''-hexamethyl-1,3,5-triazine-2,4,6-triamine
NC 195
NCGC00015100-01
NCGC00015100-02
NCGC00015100-03
NCGC00015100-06
NCGC00015100-11
NCGC00021216-03
NCGC00021216-04
NCGC00021216-05
NCGC00021216-06
NCGC00021216-07
NCI-C50259
NCI60_000871
NINDS_000772
NSC 13875
NSC-13875
NSC13875
N~2~,N~2~,N~4~,N~4~,N~6~,N~6~-Hexamethyl-1,3,5-triazine-2,4,6-triamine
Prestwick0_000946
Prestwick1_000946
Prestwick2_000946
Prestwick3_000946
Rhone Poulenc Rorer Brand of Altretamine
Rhone-Poulenc Rorer Brand of Altretamine
S1278_Selleck
SAM002564241
SMR000058181
SPBio_000754
SPBio_003071
SPECTRUM1503065
ST086739
STK749184
Spectrum2_000907
Spectrum3_000951
Spectrum4_001064
Spectrum5_001092
Spectrum_001308
UNII-Q8BIH59O7H
WLN: T6N CN ENJ BN1&1 DN1&1 FN1&1
Wassermann Brand of Altretamine
ZINC00000905
altretamine
no)-s-triazine
13Interleukin-2Phase 2487
14Immunosuppressive AgentsPhase 210422
15Antibodies, MonoclonalPhase 22413
16
Azathioprineapproved153446-86-62265
Synonyms:
446-86-6
55774-33-9 (hydrochloride salt)
6-((1-Methyl-4-nitro-1H-imidazol-5-yl)thio)-1H-purine
6-((1-Methyl-4-nitroimidazol-5-yl)thio)purine
6-(1'-Methyl-4'-nitro-5'-imidazolyl)-mercaptopurine
6-(1'-Methyl-4'-nitro-5'-imidazolyl)mercaptopurine
6-(1-Methyl-4-nitroimidazol-5-yl)thiopurine
6-(1-Methyl-4-nitroimidazol-5-ylthio)purin
6-(1-Methyl-4-nitroimidazol-5-ylthio)purin [Czech]
6-(1-Methyl-p-nitro-5-imidazolyl)-thiopurine
6-(1-Methyl-p-nitro-5-imidazolyl)thiopurine
6-(3-Methyl-5-nitro-3H-imidazol-4-ylsulfanyl)-7H-purine
6-(3-methyl-5-nitroimidazol-4-yl)sulfanyl-7H-purine
6-(Methyl-p-nitro-5-imidazolyl)-thiopurine
6-(Methyl-p-nitro-5-imidazolyl)thiopurine
6-({4-nitro-1-methyl-1H-imidazol-5-yl}sulfanyl)-7H-purine
6-1'-Methyl,4'-nitro,5'-imidazolyl mercaptopurine
6-[(1-Methyl-4-nitroimidazol-5-yl)- thio] purine
6-[(1-Methyl-4-nitroimidazol-5-yl)thio]purine
6-[(1-methyl-4-nitro-1H-imidazol-5-yl)sulfanyl]-7H-purine
6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-1H-Purine
6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-7H-purine
6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-9H-purine
A 4638
A2593_SIAL
A4638_SIAL
A4638_SIGMA
AB00443544
AB00443544-03
AC-4230
AC1L1DAL
AC1Q3Z1F
AI-981/34845012
AI3-50290
Azamun
Azamun [Czech]
Azanin
Azasan
Azasan (TN)
Azasan, Imuran, Azamun, BW-57-322, NSC-39084, Azathioprine
Azathioprin
Azathioprine
Azathioprine (JP15/USP/INN)
Azathioprine Sodium
Azathioprine [USAN:INN:BAN:JAN]
Azathioprine sodium
Azathioprinum
Azathioprinum [INN-Latin]
Azathiopurine
Azatioprin
Azatioprina
Azatioprina [INN-Spanish]
Azothioprine
B. W. 57-322
BPBio1_000054
BRD-K32821942-001-05-6
BRD-K60324116-001-01-5
BSPBio_000048
BSPBio_001876
BW 57-322
BW 57322
BW-57-322
C06837
C9H7N7O2S
CAS-446-86-6
CBDivE_013132
CCRIS 62
CHEBI:2948
CHEMBL1542
CID2265
CPD000427366
Ccucol
ChemDiv1_002659
Cytostatics
D00238
DB00993
DivK1c_000586
EINECS 207-175-4
EU-0100027
FT-0083532
HMS1568C10
 
HMS1920E17
HMS2091K19
HMS501N08
HMS594I19
HSDB 7084
IDI1_000586
Immuran
Imuran
Imuran (TN)
Imuran (tn)
Imurek
Imurel
KBio1_000586
KBio2_000464
KBio2_002427
KBio2_003032
KBio2_004995
KBio2_005600
KBio2_007563
KBio3_001376
KBio3_002906
KBioGR_000646
KBioGR_002427
KBioSS_000464
KBioSS_002433
LS-123
Lopac-A-4638
Lopac0_000027
MLS001049307
Methylnitroimidazolylmercaptopurine
MolPort-000-745-914
MolPort-000-764-262
MolPort-003-665-485
Muran
NCGC00015060-01
NCGC00015060-02
NCGC00015060-04
NCGC00015060-12
NCGC00090836-01
NCGC00090836-02
NCGC00090836-03
NCGC00090836-04
NCGC00090836-05
NCGC00090836-06
NCGC00094593-01
NCGC00094593-02
NCGC00094593-03
NCI-C03474
NINDS_000586
NSC 39084
NSC-39084
NSC39084
Oprea1_375441
Oprea1_533384
Oprea1_633462
Prestwick0_000094
Prestwick1_000094
Prestwick2_000094
Prestwick3_000094
Prestwick_41
S1721_Selleck
SAM002589938
SDCCGMLS-0065415.P001
SMR000427366
SPBio_000255
SPBio_001987
SPECTRUM1500133
STK831906
STOCK1S-20293
STOCK1S-27186
Spectrum2_000068
Spectrum3_000308
Spectrum4_000243
Spectrum5_000848
Spectrum_000064
Thiopurine 6-(1-methyl-4-nitroimidazol-5-yl)
UNII-MRK240IY2L
WLN: T56 BM DN FN HNJ IS- ET5N CNJ A1 DNW
ZINC04258316
[Methyl(nitroimidazolyl)mercaptopurine]
azathioprine
azatiopr in
cMAP_000046
17
Certolizumab pegolapproved117428863-50-7
Synonyms:
428863-50-7
CDP870
Certolizumab pegol
 
Certolizumab pegol (USAN/INN)
Certolizumab pegol (genetical recombination)
Certolizumab pegol (genetical recombination) (JAN)
Cimzia
D03441
18
Adalimumabapproved443331731-18-116219006
Synonyms:
331731-18-1
Adalimumab
Adalimumab (USAN/INN)
Adalimumab (genetical recombination)
 
Adalimumab (genetical recombination) (JAN)
D02597
Humira
Humira (TN)
Humira Pen
Ig gamma-1 chain C region
19
Methotrexateapproved14441959-05-2, 59-05-2126941
Synonyms:
4-amino-10-methylfolic acid
4-amino-N(10)-Methylpteroylglutamic acid
Abitrexate
Amethopterin
Amethopterine
Antifolan
Arbitrexate
Emtexate
Folex
HDMTX
L-Amethopterin
Ledertrexate
MTX
Metatrexan
Methopterin
Methotextrate
 
Methotrate
Methotrexat
Methotrexate
Methotrexate Sodium
Methotrexatum
Methylaminopterin
Methylaminopterinum
Metoject
Metotrexato
Mexate
Méthotrexate
N-Bismethylpteroylglutamic Acid
N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid
Otrexup
Rasuvo
Rheumatrex
Rheumatrex Dose Pack
Trexall
20
Infliximabapproved349170277-31-3
Synonyms:
Ig gamma-1 chain C region
 
Inflectra
Remicade
Remsima
21
Acetylcholineexperimental68951-84-3187
Synonyms:
ACh
Acetyl choline ion
Acetylcholine Chloride
Acetylcholine cation
 
Acetylcholinium: acetyl-Choline
Choline acetate
Choline acetate (ester)
Miochol E
O-Acetylcholine
acetylcholine chloride
22IncobotulinumtoxinA599
23Botulinum Toxins616
24Cholinergic Agents3243
25Neuromuscular Agents922
26AbobotulinumtoxinA588
27Neurotransmitter Agents14795
28OnabotulinumtoxinA588
29Peripheral Nervous System Agents18510
30Botulinum Toxins, Type A588
316-Mercaptopurine185
32Adjuvants, Immunologic1783
33AcidophilusNutraceutical482

Interventional clinical trials:

(show top 50)    (show all 118)
idNameStatusNCT IDPhase
1Measles, Mumps, and Rubella (MMR) Immunity in College StudentsCompletedNCT00962819Phase 4
2Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox DiseasesCompletedNCT00126997Phase 4
3Immunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined VaccineCompletedNCT00313950Phase 4
4Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Juvenile Idiopathic ArthritisCompletedNCT00731965Phase 4
5MMR Vaccination Among HIV-infected AdultsCompletedNCT02724852Phase 4
6Assess GSK Biologicals' MMR Vaccine (Priorix) When Given to Healthy Children at the Age of 12 to 18 Months in Singapore.CompletedNCT00388440Phase 4
7Concomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month-Old Children (V251-067)CompletedNCT00312858Phase 4
8Safety Study of a Refrigerator-Stable Formulation of VARIVAX®CompletedNCT00432731Phase 4
9MMR and Varicella Vaccine in Premature InfantsCompletedNCT00156559Phase 4
10Safety & Immunogenicity of MMR Vaccine by DSJI to That by Needle-Syringe in 15-18 Months Old ChildrenCompletedNCT02253407Phase 4
11Study of the Influence of Vaccination in HIV Viral Load and Immunologic Responses Against HIVCompletedNCT00329251Phase 4
12Comparative Study of the Immunogenicity of MMR (Measles, Mumps and Rubella) Single Dose and Multidose PresentationsRecruitingNCT01777529Phase 4
13Search for the Measles Vaccine Virus Excretion in Breast Milk of Breastfeeding Women After Postpartum Vaccination With MMRRecruitingNCT02325310Phase 4
14Induction of Immunity Against Measles in Pediatric Liver Transplant RecipientsRecruitingNCT01770119Phase 4
15The Safety and Immunogenicity Study of Rotavirus Vaccine Simultaneously Vaccinated With MR or MMR VaccineEnrolling by invitationNCT02153866Phase 4
16Responses of Premature Infants to Measles-Mumps-Rubella (MMR) and Varicella VaccinesTerminatedNCT00138255Phase 4
17A Study of An Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age (V205C-007)(COMPLETED)CompletedNCT00092391Phase 3
18Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese ToddlersCompletedNCT01188343Phase 3
19Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox DiseasesCompletedNCT00127023Phase 3
20Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027)CompletedNCT01536405Phase 3
21Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and OlderCompletedNCT02058563Phase 3
22Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136CompletedNCT00751348Phase 3
23Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox DiseasesCompletedNCT00127010Phase 3
24Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTMCompletedNCT00969436Phase 3
25Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of LifeCompletedNCT01681992Phase 3
26Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of AgeCompletedNCT02184572Phase 3
27Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of AgeCompletedNCT01621802Phase 3
28Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016)CompletedNCT00092430Phase 3
29Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy ToddlersCompletedNCT00422292Phase 3
30ProQuad™ Versus M-M-R II™ and VARIVAX™ in Healthy Children (V221-009)(COMPLETED)CompletedNCT00975507Phase 3
31Consistency Study of GlaxoSmithKline (GSK) Biologicals' MMR Vaccine (209762) (Priorix®) Comparing Immunogenicity and Safety to Merck & Co., Inc.'s MMR Vaccine (M M R®II), in Children 12 to 15 Months of AgeCompletedNCT01702428Phase 3
32Safety, Tolerability, and Immunogenicity of 3 Frozen ProQuad Consistency Lots in Healthy Children (V221-012)(COMPLETED)CompletedNCT00985153Phase 3
33Immunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in ChildrenCompletedNCT00197015Phase 3
34Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined VaccineCompletedNCT00406211Phase 3
35A Study of ProQuad in Healthy 4 to 6 Year Old Children (V221-014)CompletedNCT00985166Phase 3
36Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety StudyCompletedNCT00326183Phase 3
37Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered ConcomitantlyCompletedNCT00432042Phase 3
38Study of the Safety of Menactra® Vaccine When Administered With Other Pediatric Vaccines to Healthy ToddlersCompletedNCT00483574Phase 3
39Evaluate Vaccine Against Chickenpox and a Combined Vaccine Against 4 Viral Childhood Diseases: Measles, Mumps, Rubella and ChickenpoxCompletedNCT00226499Phase 3
40ProQuad® rHA SafetyCompletedNCT00560755Phase 3
41Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (FluMist) and Measles, Mumps, Rubella, and Varicella Vaccines Administered Concurrently to Healthy ChildrenCompletedNCT00192491Phase 3
42Frozen ProQuad Administered Concomitantly Versus Nonconcomitantly With Other Pediatric VaccinesCompletedNCT00984295Phase 3
43Comparative Study of Immunogenicity and Safety of a 2-Dose Regimen of ProQuad® Manufactured With rHACompletedNCT00566527Phase 3
44V221 Concomitant Use Study With Pneumococcal Conjugate Vaccine (V221-019)CompletedNCT00109343Phase 3
45ProQuad® Intramuscular vs SubcutaneousCompletedNCT00402831Phase 3
46Immunogenicity and Safety Study of PriorixTetra™ When Co-administered With Conjugated MenC Vaccine in Healthy ChildrenCompletedNCT01506193Phase 3
47Safety and Immune Response of Novartis MenACWY-CRM Conjugate Vaccine When Given to Healthy ToddlersCompletedNCT00626327Phase 3
48Immunogenicity and Safety of Concomitant Administration of MMR™ rHA and VARIVAX® by Intramuscular Versus Subcutaneous RouteCompletedNCT00432523Phase 3
49Safety & Immunogenicity Study of Meningococcal Vaccine GSK134612 Given With Priorix-Tetra™ to 12-23 Month-Old ChildrenCompletedNCT00474266Phase 3
50A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy ToddlersCompletedNCT00384397Phase 3

Search NIH Clinical Center for Mumps


Cochrane evidence based reviews: mumps

Genetic Tests for Mumps

About this section

Anatomical Context for Mumps

About this section

MalaCards organs/tissues related to Mumps:

33
Salivary gland, Brain, Breast, Heart, Testes, B cells, Prostate

FMA organs/tissues related to Mumps:

16
Salivary gl

Animal Models for Mumps or affiliated genes

About this section

MGI Mouse Phenotypes related to Mumps:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053707.9FADD, IFNG, IL10RB, IL12RB2, IL6, STAT1
2MP:00053797.7CD40LG, FADD, IFNG, IL10RB, IL12RB2, IL6
3MP:00053817.4FADD, IFNG, IL10RB, IL12RB2, IL2RA, IL6
4MP:00053976.0CD40LG, FADD, IFNG, IL10RB, IL12RB2, IL18R1
5MP:00053875.7CD40LG, FADD, IFNG, IL10RB, IL12RB2, IL18R1

Publications for Mumps

About this section

Articles related to Mumps:

(show top 50)    (show all 750)
idTitleAuthorsYear
1
Emerging mumps infection. (27097351)
2016
2
Immunogenicity and safety of early vaccination with two doses of a combined measles-mumps-rubella-varicella vaccine in healthy Indian children from 9a88months of age: a phase III, randomised, non-inferiority trial. (26362659)
2015
3
Seroprevalence of measles, mumps and rubella among young adults, after 20A years of universal two-dose MMR vaccination in Israel. (25891446)
2015
4
Measles-Mumps-Rubella-Varicella Combination Vaccine (ProQuad(Ar)): A Guide to Its Use in Children in the EU. (25732634)
2015
5
Mumps outbreak in the Federation of Bosnia and Herzegovina with large cohorts of susceptibles and genetically diverse strains of genotype G, Bosnia and Herzegovina, December 2010 to September 2012. (25166347)
2014
6
Mumps serum antibody levels before and after an outbreak to assess infection and immunity in vaccinated students. (25734169)
2014
7
Increased levels of cytokines in cerebrospinal fluid of children with aseptic meningitis caused by mumps virus and echovirus 30. (24313836)
2014
8
Mumps antibody response in young adults after a third dose of measles-mumps-rubella vaccine. (25734162)
2014
9
Mumps vaccine effectiveness and risk factors for disease in households during an outbreak in New York City. (24252695)
2014
10
Decline of varicella vaccination in German surveillance regions after recommendation of separate first-dose vaccination for varicella and measles-mumps-rubella. (24412300)
2014
11
Seroprevalence survey on measles, mumps, rubella and varicella antibodies in healthcare workers in Japan: sex, age, occupational-related differences and vaccine efficacy. (23574767)
2014
12
Investigation of an outbreak of hypersensitivity-type reactions during the 2004 national measles-mumps-rubella vaccination campaign in Brazil. (23246259)
2013
13
Influence of Vaccination dose and clinico-demographical factors on antibody titers against measles, rubella, mumps, and varicella-zoster viruses among university students in Japan. (24270137)
2013
14
Outbreak-related mumps vaccine effectiveness among a cohort of children and of young adults in Germany 2011. (24091837)
2013
15
Waning of maternal antibodies against measles, mumps, rubella, and varicella in communities with contrasting vaccination coverage. (23661802)
2013
16
Characterisation of mumps virus genotype C among patients with mumps in India. (23883719)
2013
17
Spermiogram part of population with the manifest orchitis during an ongoing epidemic of mumps. (22937687)
2012
18
Establishment of a standard seed lot system of an Iranian Mumps virus strain; RS-12, for mass production of mumps and MMR vaccines. (23115712)
2012
19
Seroepidemiology of mumps in Europe (1996-2008): why do outbreaks occur in highly vaccinated populations? (22687578)
2012
20
Acupuncture for mumps in children. (22972121)
2012
21
Pityriasis lichenoides et varioliformis acuta: a rare association with the measles, mumps and rubella vaccine. (23157791)
2012
22
Seroprevalence of measles, mumps, rubella, varicella-zoster and hepatitis A-C in Emirati medical students. (23217121)
2012
23
Mumps exposure of a health care provider working in a neonatal intensive care unit leads to a hospital-wide effort that prevented an outbreak. (21641085)
2011
24
Mumps virus encephalitis with symmetric claustrum lesions. (21659481)
2011
25
A 176 amino acid polypeptide derived from the mumps virus HN ectodomain shows immunological and biological properties similar to the HN protein. (20727167)
2010
26
Lower long-term immunogenicity of mumps component after MMR vaccine. (20975455)
2010
27
Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures. (20587679)
2010
28
Closer look at autism and the measles-mumps-rubella vaccine. (21071320)
2010
29
Mumps vaccine effectiveness in highly immunized populations. (20226249)
2010
30
Molecular differences between two Jeryl Lynn mumps virus vaccine component strains, JL5 and JL2. (19656963)
2009
31
An office-based prospective study of deafness in mumps. (19209100)
2009
32
Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months-2 years or 2-6 years primed with measles-mumps-rubella (MMR) vaccine. (19007835)
2009
33
Mumps virus Enders strain is sensitive to interferon (IFN) despite encoding a functional IFN antagonist. (19625458)
2009
34
Mumps: not an innocent bystander in solid organ transplantation. (19563333)
2009
35
Immunogenicity and safety of concomitant administration of a measles, mumps and rubella vaccine (M-M-RvaxPro) and a varicella vaccine (VARIVAX) by intramuscular or subcutaneous routes at separate injection sites: a randomised clinical trial. (19366435)
2009
36
Mumps outbreak on the island of Anglesey, North Wales, December 2008-January 2009. (19215718)
2009
37
Differential mechanisms of complement-mediated neutralization of the closely related paramyxoviruses simian virus 5 and mumps virus. (18440578)
2008
38
Detection of mumps virus RNA by real-time one-step reverse transcriptase PCR using the LightCycler platform. (18945836)
2008
39
The role of air travel in the spread of mumps. (18831704)
2008
40
Mumps outbreak in a highly vaccinated school population: assessment of secondary vaccine failure using IgG avidity measurements. (17498856)
2007
41
Assessing participation bias in a population-based study of measles-mumps-rubella vaccine immunity in children and adolescents aged 12-18. (17564596)
2007
42
Comparison of the safety and immunogenicity of a refrigerator-stable versus a frozen formulation of ProQuad (measles, mumps, rubella, and varicella virus vaccine live). (17502347)
2007
43
Human leukocyte antigen class II alleles and rubella-specific humoral and cell-mediated immunity following measles-mumps-rubella-II vaccination. (15655774)
2005
44
Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy. (15717298)
2005
45
Mumps epididymo-orchitis with prolonged detection of virus in semen and the development of anti-sperm antibodies. (15042662)
2004
46
The risk of aseptic meningitis associated with the Leningrad-Zagreb mumps vaccine strain following mass vaccination with measles-mumps-rubella vaccine, Rio Grande do Sul, Brazil, 1997. (12435771)
2002
47
Previous exposure to measles, mumps, and rubella--but not vaccination during adolescence--correlates to the prevalence of pancreatic and thyroid autoantibodies. (10390298)
1999
48
Mumps pancreatitis without parotitis. (4692679)
1973
49
LEUKEMOID REACTION TO MUMPS VIRUS. (14160741)
1964
50
Mumps meningoencephalitis with and without parotitis. (18147966)
1949

Variations for Mumps

About this section

Expression for genes affiliated with Mumps

About this section
Search GEO for disease gene expression data for Mumps.

Pathways for genes affiliated with Mumps

About this section

Pathways related to Mumps according to GeneCards Suite gene sharing:

(show all 46)
idSuper pathwaysScoreTop Affiliating Genes
19.7IFNG, STAT1, STAT2
2
Show member pathways
9.7IFNG, STAT1, STAT2
3
Show member pathways
9.5IL10RB, STAT1, STAT2
4
Show member pathways
9.5IFNG, IL2RA, STAT1
59.5CD40LG, IFNG, IL2RA
6
Show member pathways
9.5CD40LG, IFNG, IL2RA
79.4IFNG, IL12RB2, IL2RA
89.4IFNG, IL12RB2, IL2RA
99.4HLA-DRB1, STAT1, STAT2
109.3IL6, STAT1, STAT2
119.3IFNG, IL6, STAT1
129.3IFNG, IL6, STAT1
13
Show member pathways
9.3IFNG, IL6, STAT1
149.3IFNG, IRF2, STAT1, STAT2
159.3CD40LG, IFNG, IL6
16
Show member pathways
9.3IL12RB2, IL6, STAT1
179.2IFNG, IL6, IRF2
189.2IL2RA, IL6, STAT1
199.2CD40LG, IL2RA, IL6
209.1IFNG, IL2RA, IL6
21
Show member pathways
9.1IFNG, IL12RB2, IL18R1, IL2RA
229.0IFNG, IL6, STAT1, STAT2
239.0HLA-DRB1, IFNG, IL6
249.0HLA-DRB1, IFNG, IL6
258.9HLA-DRB1, IL2RA, IL6
268.9HLA-DRB1, IFNG, IL18R1, IL2RA
278.7FADD, IL18R1, IL6
28
Show member pathways
8.6CD40LG, HLA-DRB1, IFNG, IL10RB, STAT1
29
Show member pathways
8.5HLA-DRB1, IL10RB, IL12RB2, IL2RA, STAT1
30
Show member pathways
8.5IFNG, IL10RB, IL18R1, IL6, STAT1
31
Show member pathways
8.4IFNG, IL12RB2, IL18R1, IL6, STAT1, STAT2
32
Show member pathways
8.3HLA-DRB1, IFNG, IL12RB2, IL18R1, IL2RA, STAT1
33
Show member pathways
8.2BST2, HLA-DRB1, IFNG, IRF2, STAT1, STAT2
34
Show member pathways
8.2FADD, IFNG, IL6, STAT1, STAT2
35
Show member pathways
8.1BST2, IFNG, IL6, IRF2, STAT1, STAT2
36
Show member pathways
8.0CD40LG, IL10RB, IL12RB2, IL18R1, IL2RA, IL6
377.8IFNG, IL10RB, IL12RB2, IL2RA, IL6, STAT1
38
Show member pathways
7.8IFNG, IL10RB, IL12RB2, IL2RA, IL6, STAT1
39
Show member pathways
7.7CD40LG, IFNG, IL10RB, IL12RB2, IL18R1, IL2RA
40
Show member pathways
7.5IFNG, IL10RB, IL12RB2, IL18R1, IL2RA, IL6
417.5FADD, HLA-DRB1, IFNG, IL10RB, IL6, STAT1
42
Show member pathways
7.3FADD, HLA-DRB1, IFNG, IL2RA, IL6, STAT1
43
Show member pathways
6.7CD40LG, FADD, IL10RB, IL12RB2, IL18R1, IL2RA
44
Show member pathways
6.7CD40LG, FADD, IL10RB, IL12RB2, IL18R1, IL2RA
45
Show member pathways
6.1CD40LG, FADD, HLA-DRB1, IFNG, IL10RB, IL12RB2
46
Show member pathways
5.0BST2, CD40LG, FADD, HLA-DRB1, IFNG, IL10RB

GO Terms for genes affiliated with Mumps

About this section

Cellular components related to Mumps according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1external side of plasma membraneGO:00098979.0CD40LG, HLA-DRB1, IL6

Biological processes related to Mumps according to GeneCards Suite gene sharing:

(show all 9)
idNameGO IDScoreTop Affiliating Genes
1regulation of type I interferon-mediated signaling pathwayGO:006033810.6STAT1, STAT2
2neutrophil apoptotic processGO:000178110.2IFNG, IL6
3antigen processing and presentationGO:001988210.1HLA-DRB1, IFNG
4defense response to protozoanGO:004283210.1IFNG, IL6
5T cell homeostasisGO:00430299.6FADD, IL2RA
6apoptotic processGO:00069158.7FADD, IFNG, IL2RA, STAT1
7cytokine-mediated signaling pathwayGO:00192218.4BST2, HLA-DRB1, IFNG, IL6, STAT1, STAT2
8defense response to virusGO:00516077.8FADD, IFNG, IL10RB, IL6, STAT1, STAT2
9immune responseGO:00069557.5HLA-DRB1, IFNG, IL10RB, IL18R1, IL2RA, IL6

Sources for Mumps

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet